EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Dendritic Cells at the Center of Reactive Tumor Immunity

Lomax Pass, Matthew F Krummel iD

Immunological Reviews · 2025-11 · 336 (1)

DOI: 10.1111/imr.70072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 16.11.2025. Verfasst von Lomax Pass und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Dendritic Cells, Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 169 Literaturangaben. Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elimination of tumors is typically dependent on T cells, which require prior or ongoing activation signals. These dependencies form the basis for our understanding of “tumor‐reactive immunity” and for the successes of immunotherapies, particularly immune checkpoint blockades. Over the years, tremendous work has been done towards understanding the biology of this reactive immunity and early investigation identified dendritic cells (DC) as key contributors. Recent advances have shed more light on dendritic cell heterogeneity in tumors, revealing specialized roles for each subtype. In addition, the network of cellular interactions surrounding DCs has grown as additional cell types have been revealed to variously influence how the immune system can become most effective at eliminating malignancies. Greater understanding of intratumoral DC biology has empowered investigators to engineer dendritic cell vaccines and consider other approaches to augment this component of reactive immunity, towards the generation of anti‐tumor immune responses de novo . In this review, we will discuss the state of the field, recent advances and suggest what the near future of scientific inquiry could entail.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsNeoplasmsCancer VaccinesHumansAnimalsImmunotherapyTumor MicroenvironmentCell Communication

Stichwörter der Autor:innen

dendritic cellstumor immunologytumor microenvironment

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • Department of Pathology, University of California, San Francisco, San Francisco, California, USA.
  • UCSF Bakar ImmunoX Initiative, University of California, San Francisco, San Francisco, California, USA.

ORCID-Profile: Matthew F Krummel

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Pass, L., & Krummel, M. F. (2025). Dendritic Cells at the Center of Reactive Tumor Immunity. Immunological Reviews, 336(1). https://doi.org/10.1111/imr.70072

Vancouver

Pass L, Krummel MF. Dendritic Cells at the Center of Reactive Tumor Immunity. Immunological Reviews. 2025;336(1). doi:10.1111/imr.70072

BibTeX
@article{Pass2025,
  author = {Pass, Lomax and Krummel, Matthew F},
  title = {Dendritic Cells at the Center of Reactive Tumor Immunity},
  journal = {Immunological Reviews},
  year = {2025},
  volume = {336},
  number = {1},
  doi = {10.1111/imr.70072}
}
Kostenlos starten →